Oxford Vaccinology Programme - at the University of Oxford
The Oxford Vaccinology Programme provides state-of-the-art teaching in
both veterinary and human vaccinology, drawing on the experience of
Oxford University, the world-renowned Jenner Institute, based in Oxford,
and the Institute for Animal Health (IAH). We work with the world's
leading vaccinology specialists from industry and academia to provide
short course training in a range of areas.
Clinical Vaccine Development - 23 to 24 April 2012
The course will be designed in close collaboration with clinicians,
veterinarians and industrial partners who conduct clinical trials to
* An overview of pre-clinical testing and the pathway from
pre-clinical testing to field trials.
* A more detailed discussion of vaccine immunogenicity, testing
vaccine immunogenicity in the field and the need for correlates of
immune protection. The different phases of vaccine testing from Phase I
* An overview of the development of veterinary vaccines.
* An introduction to the principles and conduct of Good Clinical
Vaccine Biomanufacturing - 25 to 26 April 2012
The course will be designed in close collaboration with our industrial
partners to provide:
* An overview of vaccine markets and growth drives for developed
and developing settings.
* An overview of the biomanufacturing processes used for the
production of a spectrum of vaccines.
* The principles of GMP (Good Manufacturing Practice) and how
these are applied to vaccine production.
* An introduction to Quality Assurance and the use of molecular
methods to verify quality.
Human and Veterinary Vaccinology - 26 to 30 November 2012
The Human and Veterinary Vaccinology course is a five-day Master's level
course designed to stand alone and cover all aspects of vaccinology.
The course includes contributions from 18 world-leading experts,
* Prof David Salisbury (Director of Immunisation, UK Department
* Dr Mike Whelan (Head of R & D, iQur Ltd)
* Dr Vasee Moorthy (Department of Immunization, Vaccines &
Biologicals, World Health Organisation)
* Prof Andrew Pollard (Director, Oxford Vaccine Group,
University of Oxford)
* Dr Laura Martin (Development Project Leader, Novartis Vaccines
Institute for Global Health)
* Prof Adrian Hill (Director, Jenner Institute, University of
For more details or to book a place please visit our website
You may leave the list at any time by sending the command
to [log in to unmask], leaving the subject line blank.